“Twenty-five years ago, we founded SkinMedica® with a vision—to create a skincare line that’s both scientific and luxurious, yet easy to use,” reflected Dr. Kimberly Butterwick, a double board-certified dermatologist and SkinMedica® co-founder. “Our breakthrough TNS® product, developed through a unique process that harnessed growth factors, transformed SkinMedica® from a startup into a brand known for innovation and excellence.”

“Beautiful skin is timeless,” Dr. Butterwick continues. “For 25 years, SkinMedica® has helped people feel more confident in their own skin, and I continue to count on them to provide science-based solutions to address my patients’ key skincare concerns. As we celebrate this anniversary, I look forward to seeing how SkinMedica® continues to innovate and provide exceptional skincare in the next 25 years.”

Same Day Appointments Available

Book a consultation online

Join our

Inner Circle Referral Program

Get $100 Off* Botox or Dysport for You and Your Friend

Background Illustration Texture

You’re Invited To Our Webinar

The Perfect Treatment Plan

with Jameson T. Loyal, MD, FAAD

Strategic Layering & Timing of Injectables & Lasers for the Holidays

Tuesday, November 11th

Register Here

Exclusive Offer:

The first 3 attendees to schedule a combination treatment will receive 15% off their treatment, plus a complimentary skincare basket.*

*Terms and Conditions Apply
CLDerm Dr. Loyal Webinar Banner

You’re Invited to our Webinar!

You’re Invited to our Webinar! 

Get answers directly from Douglas C. Wu, MD, PhD at our live webinar with an open Q&A.

Register Here

The first 3 attendees to schedule a Thermisculpt treatment with Dr. Wu will receive 15% off their treatment, plus a complimentary advanced skincare consultation.*

*Treatment must be completed by the end of December 2025. Terms & conditions may apply.

September 24th at 5:30pm

*Complimentary consultations are only available with Dr. Zubair or Dr. Darji. Hair loss treatment must be completed with Dr. Zubair or Dr. Darji by the end of December 2025. Terms & conditions may apply.